Jump to content

Streptomyces coeruleorubidus

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Ninjatacoshell (talk | contribs) at 21:30, 1 October 2022 (speciesbox). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Streptomyces coeruleorubidus
Scientific classification Edit this classification
Domain: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Streptomycetales
Family: Streptomycetaceae
Genus: Streptomyces
Species:
S. coeruleorubidus
Binomial name
Streptomyces coeruleorubidus
(Preobrazhenskaya 1957) Pridham et al. 1958 (Approved Lists 1980)[1]
Type strain
AS 4.1678, ATCC 13740, ATCC 23900, BCRC 11463, CBS 796.68, CCRC 11463, CGMCC 4.1678, DSM 40145, ETH 24205, Gause12531/54, IFO 12855, IMET 42060, INA 12531/54, ISP 5145, JCM 4359, KCC S-0359, KCCS-0359, KCTC 1743, KCTC 1922, NBIMCC 1152, NBRC 12855, NCIB 9620, NCIMB 9620, NCIMB 9833, NRRL B-2569, NRRL-ISP 5145, PSA 181, RIA 1132, VKM Ac-576, Waksman 3840
Synonyms
  • "Actinomyces coeruleorubidus" Preobrazhenskaya 1957

Streptomyces coeruleorubidus is a bacterium species from the genus of Streptomyces which has been isolated from marine sediment.[1][2] Streptomyces coeruleorubidus produces the following medications: pacidamycin 1, baumycin B1, baumycin B2, baumycin C1, feudomycin A, feudomycin B, feudomycin C, ficellomycin, feudomycinone A, and rubomycin.[2][3][4][5][6][7][8][9]

Further reading

  • Kandula, Siva Kumar; Terli, Ramana (May 2013). "Production, purification and characterization of an antimicrobial compound from marine Streptomyces coeruleorubidus BTSS-301". Journal of Pharmacy Research. 7 (5): 397–403. doi:10.1016/j.jopr.2013.04.047.
  • Yoshimoto, A; Oki, T; Takeuchi, T; Umezawa, H (October 1980). "Microbial conversion of anthracyclinones to daunomycin by blocked mutants of Streptomyces coeruleorubidus". The Journal of Antibiotics. 33 (10): 1158–66. doi:10.7164/antibiotics.33.1158. PMID 7451367.
  • Fronko, RM; Lee, JC; Galazzo, JG; Chamberland, S; Malouin, F; Lee, MD (December 2000). "New pacidamycins produced by Streptomyces coeruleorubidus, NRRL 18370". The Journal of Antibiotics. 53 (12): 1405–10. doi:10.7164/antibiotics.53.1405. PMID 11217807.
  • Shang, Ke; Hu, Youjia; Zhu, Chunbao; Zhu, Baoquan (22 November 2007). "Production of 4'-epidaunorubicin by metabolic engineering of Streptomyces coeruleorubidus strain SIPI-1482". World Journal of Microbiology and Biotechnology. 24 (7): 1107–1113. doi:10.1007/s11274-007-9610-5. S2CID 84366644.
  • Blumauerová, M; Královcová, E; Matĕjů, J; Jizba, J; Vanĕk, Z (1979). "Biotransformations of anthracyclinones in Streptomyces coeruleorubidus and Streptomyces galilaeus". Folia Microbiologica. 24 (2): 117–27. doi:10.1007/bf02927295. PMID 456946. S2CID 7878810.
  • Oki, T; Matsuzawa, Y; Kiyoshima, K; Yoshimoto, A; Naganawa, H; Takeuchi, T; Umezawa, H (July 1981). "New anthracyclines, feudomycins, produced by the mutant from Streptomyces coeruleorubidus ME130-A4". The Journal of Antibiotics. 34 (7): 783–90. doi:10.7164/antibiotics.34.783. PMID 7287580.
  • ed.-in-chief, George M. Garrity (2012). Bergey's manual of systematic bacteriology (2nd ed.). New York: Springer Science + Business Media. ISBN 978-0-387-68233-4. {{cite book}}: |last1= has generic name (help)
  • H., Kersten; W., Kersten (1974). Inhibitors of Nucleic Acid Synthesis Biophysical and Biochemical Aspects. Berlin, Heidelberg: Springer Berlin Heidelberg. pp. 1–184. doi:10.1007/978-3-642-80855-5. ISBN 3-642-80855-7. PMID 4143460. S2CID 37777287. {{cite book}}: |journal= ignored (help)
  • Ravina, Enrique (2011). The evolution of drug discovery : from traditional medicines to modern drugs (1. Aufl. ed.). Weinheim: Wiley-VCH. ISBN 978-3-527-32669-3.
  • Knölker, edited by Hans-Joachim (2012). The Alkaloids (1st ed.). Burlington: Elsevier Science. ISBN 978-0-12-397758-8. {{cite book}}: |first1= has generic name (help)

See also

References

  1. ^ a b LPSN bacterio.net
  2. ^ a b Deutsche Sammlung von Mikroorganismen und Zellkulturen [1]
  3. ^ Oki, T; Matsuzawa, Y; Kiyoshima, K; Yoshimoto, A; Naganawa, H; Takeuchi, T; Umezawa, H (July 1981). "New anthracyclines, feudomycins, produced by the mutant from Streptomyces coeruleorubidus ME130-A4". The Journal of Antibiotics. 34 (7): 783–90. doi:10.7164/antibiotics.34.783. PMID 7287580.
  4. ^ Collins, Peter M., ed. (2006). Dictionary of carbohydrates with CD-ROM (2nd ed.). Boca Raton: CRC/Taylor & Francis. ISBN 0-8493-7765-X.
  5. ^ Roberts, edited by B.W. Bycroft ; contributors, A.A. Higton, A.D. (1988). Dictionary of antibiotics and related substances. London: Chapman and Hall. ISBN 0-412-25450-6. {{cite book}}: |first1= has generic name (help)CS1 maint: multiple names: authors list (link)
  6. ^ R., Hänsel (1980). Pharmazeutische Biologie Spezieller Teil. Berlin, Heidelberg: Springer Berlin Heidelberg. ISBN 3-642-67591-3.
  7. ^ al.], J.M. Lackie [editor] ; authors contributing to earlier editions, S.E. Blackshaw ... [et (2007). The dictionary of cell and molecular biology (4th ed.). Amsterdam: Elsevier. ISBN 978-0-08-055034-3. {{cite book}}: |first1= has generic name (help)CS1 maint: multiple names: authors list (link)
  8. ^ Gennilloud, Edited by Olga; Vicente, Francisca (2012). Drug discovery from microbial natural products. Cambridge: Royal Society of Chemistry. ISBN 978-1-84973-361-8. {{cite book}}: |first1= has generic name (help)
  9. ^ RS, Satoskar; Nirmala, Rege; SD, Bhandarkar (2015). Pharmacology and Pharmacotherapeutics. Elsevier Health Sciences. ISBN 978-81-312-4371-8.


Stub icon

This Streptomyces-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Streptomyces_coeruleorubidus&oldid=1113513743"